Homocysteinaemia and coronary artery disease: A case-control study in a Tunisian population;Homocystéinémie et maladie coronaire: Étude cas-témoins dans une population Tunisienne

Archives des Maladies du Coeur et des Vaisseaux

Volumn 99, Issue 9, 2006, Pages 781-785

  Souissi, M ^a   Feki, M ^a   Mourali, S ^a   Enneifer, M ^a   Omar, S ^a   Sanhaji, H ^a   Mechmeche, R ^a   Mebazaa, A ^a   Kaabachi, N ^a  

^a LA RABTA HOSPITAL   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; HOMOCYSTEINE;

ADULT; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEMALE; HOMOCYSTINURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; THROMBOGENESIS; ANGIOCARDIOGRAPHY; BLOOD; CASE CONTROL STUDY; CORONARY ARTERY ATHEROSCLEROSIS; MIDDLE AGED; TUNISIA;

CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; TUNISIA;

EID: 33846837220     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Thom TJ. International mortality from heart disease : rates and trends. Int J Epidemiol 1989;18(Suppl 1):S20-8.
2. Jacobsen DW. Homocysteine and vitamins in cardiovascular disease. Clin Chem 1998;44:1833-43.
3. de Ferranti S, Rifai N. C-reactive protein and cardiovascular disease : a review of risk prediction and interventions. Clin Chim Acta 2002;317:1-15.
4. Farmer JA, Torre-Amione G. Atherosclerosis and inflammation. Curr Atheroscler Rep 2002;4:92-8.
5. Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. J Am Med Assoc 1992;268:877-81.
6. Boushey CJ, Omenn G, Motulsky AG. A Quantitative assessment of plasma homocysteine as a risk factor for vascular disease. J Am Med Assoc 1995;274:1049-57.
7. Arnesen E, Refsum H, Bonaa KH, Ueland PM, Forde OH, Nordrehaug JE. Serum total homocysteine and coronary heart disease. Int J Epidemiol 1995;24:704-9.
8. Graham IM, Daly LE, Refsum H, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. J Am Med Assoc 1997;277:1775-81.
9. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337:230-6.
10. Wald NJ, Watt HC, Law MR, et al. Homocysteine and ischemic heart disease : results of a prospective study with implications regarding prevention. Arch Intern Med 1998;158:862-7.
11. Ford ES, Smith SJ, Stroup DF, Steinberg KK, Mueller PW, Thaker SB. Homocyst(e)ine and cardiovascular disease : a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int J Epidemiol 2002;31:59-70.
12. Sipahi E, Taskin G, Kumbasar D, et al. Hyperhomocysteinemia and coronary artery disease in the Turkish population. Acta Cardiol 2002;57:415-20.
13. Matetzky S, Freidmark D, Ben-Ami S, et al. Association of elevated homocysteine levels with higher risk of recurrent coronary events and mortality in patients with acute myocardial infarction. Arch Intern Med 2003;163:1993-7.
14. Morales JJ, Sanchez B, Verdejo J, Ponce de Leon S, Mutchinick OM. Hyperhomocysteinemia as risk factor in a Mexican population. Arch Cardiol Mex 2003;73:103-5.
15. Chasan-Taber L, Selhub J, Rosenberg IH, et al. A prospective study of folate and vitamin B 6 and risk of myocardial infarction in US physicians. J Am Coll Nutr 1996;15:136-43.
16. Alfthan G, Aro A, Gey KF. Plasma homocysteine and cardiovascular disease mortality [Letter]. Lancet 1997;349:397.
17. Evans RW, Shaten BJ, Hempel JD, Cutler JA, Kuller LH. Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial. Arterioscler Thromb Arterioscler Thromb Vasc Biol 1997;17:1947-53.
18. Folsom AR, Nieto FJ, McGovern PG, et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins : the Atherosclerosis Risk in Communities (ARIC) study. Circulation 1998;98:204-10.
19. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998;49:31-62.
20. Snehaltha C, Ramachandran A, Satyavani K, Sivasankari S, Sathyamurthy I, Viswanthan V. Plasma homocysteine concentration and coronary artery disease in Asian Indians. J Assoc Physicians India 2002;50:1229-31.
21. Boufidou AI, Makedou AD, Adamidis DN, et al. Association between plasma homocysteine levels and coronary artery disease : a population-based study in northern Greece. Curr Med Res Opin 2004;20:175-80.
22. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
23. Benoit C, Furber A, Le Bouil A, et al. L'homocystéine plasmatique n'est pas un facteur prédictif de resténose après angioplastie coronaire. Arch Mal Cœur Vaiss 1999;92:1457-60.
24. Blacher J, Czernichow S, Horrellou MH, et al. Homocystéine, acide folique, vitamines du groupe B et risque cardiovasculaire. Arch Mal Cœur Vaiss 2005;98:145-52.
25. Nygard O, Refsum H, Ueland PM, et al. Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. Am J Clin Nutr 1997;65:136-43.
26. Hoogeveen EK, Kostense PJ, Beks PJ, et al. Hyperhomocysteinemia is associated with an increased risk or cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. Arterioscler Thromb Vasc Biol 1998;18:133-8.
27. Virdis A, Ghiadoni L, Salvetti G, Versari D, Taddei S, Savett A. Hyperhomocysteinemia : is this a novel risk factor in hypertension. J Nephrol 2002;15:414-21.
28. Ben Romdhane H, Haouala H, Belhani A, et al. La transition épidémiologique : ses déterminants et son impact sur les systèmes de santé à travers l'analyse de la tendance des maladies cardiovasculaires en Tunisie. Tunis Med 2005;83(Suppl 5):S1-S7.
29. Blacher J, Montalescot G, Ankri A, et al. Hyperhomocysté inémie chez des patients coronariens: à propos d'une étude sur 102 sujets. Arch Mal Cœur Vaiss 1996;89:1241-6.
30. Montalescot G, Ankri A, Chadefaux-Vekemans B, et al. Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery disease. Int J Cardiol 1997;60:295-300.
31. Bozkurt A, Toyaksi H, Acartuek E, Tuli A, Cayli M. The effects of hyperhomocyteinemia on the presence, extent, and severity of coronary artery disease. Jpn Heart J 2003;44:357-68.